Indica Labs has received FDA clearance for its HALO AP Dx, a digital pathology platform for primary diagnosis. This 510(k) clearance allows the system to be utilized in conjunction with the Hamamatsu NanoZoomer S360MD slide scanner for in-vitro diagnostic use. The HALO AP and HALO AP Dx are available with a comprehensive suite of diagnostic tools and features for efficient and accurate image evaluation, management, and collaboration. The system is interoperable, allowing users to adapt the platform to meet their needs and incorporate it into their existing laboratory workflows. The platform helps labs create a custom-built environment for digital pathology for a variety of pathologic specialties, even those with unique technical requirements. It can be deployed in either a cloud-based or on-premises environment, enabling users to choose how their data is stored.